Keywords: Complement; Standardization; Therapeutics; Diagnostic techniques and procedures; Pre-analytic; Quality control; CH50; sC5b-9; Complement activation; Complement diagnostics;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Complement; Therapeutics; Diagnostics; Eculizumab; CH50;
Keywords: Thrombotic microangiopathy; Eculizumab; CH50; Eculizumab pharmacokinetics; Hematopoietic stem cell transplant
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure
Keywords: BVAS v3; Complication; Immunoglobulin; SVR; ACC; asymptomatic circulating cryoglobulin; BVAS.v3; Birmingham Vasculitis Activity Score version 3; CC; circulating cryoglobulin; CH50; total hemolytic complement fraction; CV; cryoglobulinemic vasculitis; DAA;
Virologic, Clinical, and Immune Response Outcomes of Patients With Hepatitis C Virus-Associated Cryoglobulinemia Treated With Direct-Acting Antivirals
Keywords: Cryoglobulinemic Vasculitis; Hepatitis C; DAA; Antiviral Therapy; ACC; asymptomatic circulating cryoglobulins; BVAS.v3; Birmingham Vasculitis Activity Score version 3; C4; complement 4 fraction; CH50; 50% hemolytic complement activity; CV; cryoglobulinemi
Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition
Keywords: Complement activation; C5a blockade; Trypsin; Thrombin; Eculizumab; aHUS; atypical hemolytic uremic syndrome; APH50; 50% haemolytic complement activity of alternative pathway; C3N; C3 glomerulonephritis; CH50; 50% haemolytic complement activity of classic
Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex
Keywords: AP; alternative pathway; CH50; the amount of serum (μl) giving 50% hemolysis of sheep erythrocytes; CFD; complement fixation diluents buffer; CP; classical pathway; DIC; disseminated intravascular coagulation; EGF; endothelial growth factor domain; FB; F
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
Keywords: Thrombotic microangiopathy; Eculizumab; CH50; Membrane attack complex; Complement; sC5b-9;
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA) Disease-Oriented Group
Keywords: ADAMTS13; a disintegrin and metalloprotease with a thrombospondin type 1 motif, member 13; AH50; complement alternate pathway assay; CH50; total hemolytic complement assay; CFB; complement factor B; CFHR1; complement factor H-related protein 1; CFI; com
Social isolation disrupts innate immune responses in both male and female prairie voles and enhances agonistic behavior in female prairie voles (Microtus ochrogaster)
Keywords: CH50; Corticosterone; Hemolytic complement; Psychosocial stress; Aggression; Microtus ochrogaster;
EGFR siRNA lipid nanocapsules efficiently transfect glioma cells in vitro
Keywords: Nanomedicine; Brain tumor; Gene therapy; CH50; U87MG;
A novel recombinant fibrinogenase of Agkistrodon acutus venom protects against hyperacute rejection via degradation of complements
Keywords: ADP; adenosine diphosphate; ATII; antithrombin; CH50; complement hemolytic activity 50; CVF; cobra venom factor; HAR; hyperacute rejection; HUVEC; human umbilical vein endothelial cell; HR; heart rate; IgM; immunoglobulin M; LVDP; left ventricular develop
Serum killing of Ureaplasma parvum shows serovar-determined susceptibility for normal individuals and common variable immuno-deficiency patients
Keywords: SV; serovar; U; Ureaplasma; CVID; common variable immunodeficiency; MAC; membrane attack complex; HPA; health protection agency; USM; Ureaplasma specific growth medium; CFB; complement fixation buffer; VBS; veronal buffered saline; HI-NHS; heat inactivate
Three novel single-nucleotide polymorphisms of complement component 4 gene (C4A) in Chinese Holstein cattle and their associations with milk performance traits and CH50
Keywords: Bovine; C4A gene; SNP; CH50; Mastitis; C4 serum level
Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a
Keywords: BSA; bovine serum albumin; C3a; complement component C3a; C3a desArg; inactive form of complement component C3a; CH50; total complement activation assay; CuOx-LDL; low-density lipoprotein oxidized by exposure to copper ions; CWPS; Streptococcus pneumoniae
Anticomplementary activity of equine whole IgG antivenoms: comparison of three fractionation protocols
Keywords: Antivenom; Anticomplementary activity; Early adverse reactions; IgG; CH50;